EFFICACY OF SGLT2 INHIBITORS ON LV DIASTOLIC DYSFUNCTION AND PREVENTION OF NEW ONSET ATRIAL FIBRILLATION IN DIASTOLIC HEART FAILURE PATIENTS - NI

DrSubbiah0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•All patients aged more than 18 years of age diagnosed with Diastolic Heart failure are included
•Diastolic Heart failure patients under treatment with either Dapagliflozin 10 mg or Telmisartan 40mg
•LVEF > 45% documented by echocardiography

•Patients with systolic Heart failure with EF < 45%
•Uncontrolled Hypertension with systolic
•BP >140 mmhg or Diastolic Bp >90 mmhgare excluded
•Uncontrolled Diabetis mellitus with FBS >125 mg/dl or PPBS >200 mg/dl are excluded
•Patients who need step up treatment in Baseline Regimen dosage for Hypertension or Diabetes mellitus during course of study are excluded
•Patients who develop acute exacerbation or symptoms of congestive HF or those who need treatment with Diuretics during course of study are excluded
•Presence of cardiomyopathy due to infiltrative disorders- amyloidosis, sarcoidosis are excluded
•Dyspnea due to primary lung disorder

发起方

DrSubbiah